Efficacy of Carminal in Helicobacter Pylori Gastritis

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 4, 2025

Primary Completion Date

August 3, 2026

Study Completion Date

October 5, 2026

Conditions
H Pylori GastritisH Pylori InfectionH Pylori EradicationGastritis Associated With Helicobacter PyloriGastric Mucosal Lesion
Interventions
DIETARY_SUPPLEMENT

Carminal Oral solution

Carminal is an oral dietary supplement presented in 30 ml vials, administered once daily (1 vial BID). It contains Aloe vera extract, olive extract, glutamic acid, zinc, and other components with potential antioxidant, anti-inflammatory, and immunomodulatory effects on gastric mucosa. In this study, Carminal is administered for 14 days during standard Helicobacter pylori eradication therapy, followed by 12 weeks of continued treatment post-eradication to support mucosal recovery and improve dyspeptic symptoms.

OTHER

Placebo

Placebo is an oral solution presented in 30 ml vials, identical in appearance, taste, color, and smell to Carminal, but without any active ingredients. It is administered once daily (1 vial BID) for 14 days during standard Helicobacter pylori eradication therapy, followed by 12 weeks of continued placebo treatment post-eradication. This comparator is used to evaluate the efficacy of Carminal in mucosal recovery and symptom improvement in patients with H. pylori positive gastritis.

Trial Locations (2)

11000

RECRUITING

Clinical Center of Serbia - Clinic for Gastroenterohepatology, Belgrade

RECRUITING

Zvezdara Medical Center - Department of Gastroenterology, Belgrade

All Listed Sponsors
lead

Catalysis SL

INDUSTRY

NCT07179237 - Efficacy of Carminal in Helicobacter Pylori Gastritis | Biotech Hunter | Biotech Hunter